Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Patients With Stage IV Colorectal Cancer After Surgery

Recent studies have shown patient-derived tumor organoids can predict the drug response of patients with cancer. However, the prognostic value of patient-derived tumor organoid–based drug tests in predicting the progression-free survival of patients with stage IV colorectal cancer after surgery rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ting, Tang, Yuting, Pan, Wenjun, Yan, Botao, Hao, Yifan, Zeng, Yunli, Chen, Zexin, Lan, Jianqiang, Zhao, Shuhan, Deng, Chuxia, Zheng, Hang, Yan, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Dynamic Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072204/
https://www.ncbi.nlm.nih.gov/pubmed/36898057
http://dx.doi.org/10.1097/DCR.0000000000002511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072204/
https://www.ncbi.nlm.nih.gov/pubmed/36898057
http://dx.doi.org/10.1097/DCR.0000000000002511

Ejemplares similares